Global Measles Surge in 2026: Declining Vaccination Rates Fuel Outbreaks

The year 2026 is witnessing a significant resurgence of measles globally, with the World Health Organization (WHO) estimating that nearly 11 million people will contract the virus. This alarming trend is largely attributed to a worldwide decline in measles vaccination rates, which has created vulnerable populations susceptible to outbreaks. The virus is spreading across continents, with major outbreaks reported in Africa, Asia, the Americas, and Europe. India, in particular, is experiencing a sharp increase in measles cases. In the first half of 2026, the country reported 26,627 cases, making it the second-highest tally globally, surpassed only by Bangladesh. This marks a reversal from previous years, as India had reported fewer cases in 2024 and 2025. The rise in India has raised concerns about surveillance transparency and the pace of the country's elimination drive. Globally, the proportion of children receiving the first dose of the measles vaccine was 84% in 2025, a slight decrease from 86% in 2019. In many countries, vaccination coverage has fallen below the critical 95% threshold required to maintain herd immunity, allowing the virus to spread more easily. For instance, in the United States, vaccination coverage among kindergartners has decreased, leading to an increase in measles cases and putting the country at risk of losing its measles elimination status, which it has held since 2000. In Europe, several countries, including the United Kingdom, have also lost their measles elimination status due to sustained transmission fueled by declining vaccination rates. The consequences of these declining vaccination rates are severe. Measles is a highly contagious disease that can lead to serious complications, including deafness, blindness, pneumonia, encephalitis, and death, particularly among unvaccinated or under-vaccinated children under five years of age. While a safe and cost-effective vaccine exists, an estimated 95,000 people died from measles globally in 2024. The measles vaccine has averted an estimated 59 million deaths between 2000 and 2024, highlighting its crucial role in public health. Factors contributing to the decline in vaccination rates are multifaceted and include vaccine hesitancy, misinformation, reduced access to routine childhood vaccinations, and, in some regions, insufficient vaccine supply and operational challenges. In India, migratory populations and vaccine hesitancy have been identified as challenges in controlling outbreaks. In Bangladesh, political instability and reduced global funding have contributed to vaccine shortages. Public health organizations, including the WHO and UNICEF, are urging countries to strengthen their immunization programs, conduct mass vaccination campaigns, and improve surveillance systems to combat the rising measles cases. The situation underscores the importance of maintaining high vaccination coverage to prevent the resurgence of diseases that were once considered controlled or eliminated.

Frequently Asked Questions

Read Full Story on Quick Digest